Neville Rodie & Shaw’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $105M | Sell |
243,027
-7,132
| -3% | -$2.16M | 6.82% | 2 |
|
|
2026
Q1 | $53.4M | Sell |
250,159
-9,813
| -4% | -$2.19M | 3.88% | 5 |
|
|
2025
Q4 | $44.5M | Sell |
259,972
-6,782
| -3% | -$1.05M | 3.14% | 5 |
|
|
2025
Q3 | $35.7M | Sell |
266,754
-47,688
| -15% | -$5.05M | 2.58% | 8 |
|
|
2025
Q2 | $30.6M | Sell |
314,442
-8,250
| -3% | -$654K | 2.27% | 9 |
|
|
2025
Q1 | $23.5M | Sell |
322,692
-27,100
| -8% | -$2.13M | 1.84% | 14 |
|
|
2024
Q4 | $25.3M | Sell |
349,792
-4,638
| -1% | -$352K | 1.84% | 14 |
|
|
2024
Q3 | $28.9M | Sell |
354,430
-8,440
| -2% | -$734K | 2.13% | 10 |
|
|
2024
Q2 | $38.6M | Buy |
362,870
+110
| +0% | +$10.6K | 2.93% | 6 |
|
|
2024
Q1 | $35.2M | Sell |
362,760
-7,580
| -2% | -$667K | 2.69% | 7 |
|
|
2023
Q4 | $29M | Sell |
370,340
-530
| -0.1% | -$36.1K | 2.37% | 8 |
|
|
2023
Q3 | $23.2M | Sell |
370,870
-1,280
| -0.3% | -$84.1K | 2.07% | 10 |
|
|
2023
Q2 | $23.9M | Sell |
372,150
-780
| -0.2% | -$44K | 2.06% | 9 |
|
|
2023
Q1 | $19.8M | Sell |
372,930
-1,220
| -0.3% | -$59.9K | 1.79% | 12 |
|
|
2022
Q4 | $15.7M | Sell |
374,150
-3,320
| -0.9% | -$139K | 1.48% | 21 |
|
|
2022
Q3 | $13.8M | Sell |
377,470
-3,630
| -1% | -$162K | 1.36% | 24 |
|
|
2022
Q2 | $16.2M | Sell |
381,100
-6,290
| -2% | -$299K | 1.45% | 20 |
|
|
2022
Q1 | $20.4M | Sell |
387,390
-1,170
| -0.3% | -$68.1K | 1.51% | 18 |
|
|
2021
Q4 | $27.9M | Sell |
388,560
-220
| -0.1% | -$13.8K | 1.98% | 9 |
|
|
2021
Q3 | $22.1M | Sell |
388,780
-5,570
| -1% | -$339K | 1.72% | 13 |
|
|
2021
Q2 | $25.7M | Buy |
394,350
+430
| +0.1% | +$27.1K | 1.98% | 9 |
|
|
2021
Q1 | $23.4M | Sell |
393,920
-3,230
| -0.8% | -$176K | 1.94% | 8 |
|
|
2020
Q4 | $18.8M | Sell |
397,150
-6,680
| -2% | -$281K | 1.62% | 16 |
|
|
2020
Q3 | $13.4M | Buy |
403,830
+27,680
| +7% | +$954K | 1.26% | 24 |
|
|
2020
Q2 | $12.2M | Buy |
376,150
+4,090
| +1% | +$112K | 1.26% | 22 |
|
|
2020
Q1 | $8.93M | Sell |
372,060
-3,020
| -0.8% | -$87K | 1.09% | 28 |
|
|
2019
Q4 | $11M | Sell |
375,080
-2,770
| -0.7% | -$73.6K | 1.08% | 28 |
|
|
2019
Q3 | $8.73M | Sell |
377,850
-4,950
| -1% | -$104K | 0.92% | 32 |
|
|
2019
Q2 | $7.19M | Sell |
382,800
-17,470
| -4% | -$331K | 0.76% | 40 |
|
|
2019
Q1 | $7.17M | Sell |
400,270
-37,320
| -9% | -$623K | 0.76% | 43 |
|
|
2018
Q4 | $5.96M | Sell |
437,590
-15,440
| -3% | -$221K | 0.72% | 45 |
|
|
2018
Q3 | $6.87M | Sell |
453,030
-24,000
| -5% | -$410K | 0.68% | 49 |
|
|
2018
Q2 | $8.25M | Sell |
477,030
-580
| -0.1% | -$11.2K | 0.87% | 40 |
|
|
2018
Q1 | $9.7M | Sell |
477,610
-1,200
| -0.3% | -$23.8K | 1.07% | 30 |
|
|
2017
Q4 | $8.81M | Buy |
478,810
+17,210
| +4% | +$338K | 0.93% | 33 |
|
|
2017
Q3 | $8.54M | Sell |
461,600
-24,980
| -5% | -$405K | 0.95% | 34 |
|
|
2017
Q2 | $6.88M | Sell |
486,580
-19,040
| -4% | -$279K | 0.79% | 44 |
|
|
2017
Q1 | $6.49M | Sell |
505,620
-45,290
| -8% | -$532K | 0.74% | 48 |
|
|
2016
Q4 | $5.83M | Hold |
550,910
| – | – | 0.69% | 51 |
|
|
2016
Q3 | $5.22M | Buy |
550,910
+2,140
| +0.4% | +$19.5K | 0.61% | 55 |
|
|
2016
Q2 | $4.61M | Buy |
548,770
+2,960
| +0.5% | +$23.8K | 0.55% | 59 |
|
|
2016
Q1 | $4.51M | Sell |
545,810
-2,480
| -0.5% | -$18K | 0.55% | 63 |
|
|
2015
Q4 | $4.35M | Buy |
548,290
+17,220
| +3% | +$130K | 0.52% | 67 |
|
|
2015
Q3 | $3.47M | Sell |
531,070
-1,080
| -0.2% | -$7.91K | 0.43% | 74 |
|
|
2015
Q2 | $4.33M | Buy |
532,150
+31,750
| +6% | +$249K | 0.47% | 66 |
|
|
2015
Q1 | $3.52M | Buy |
500,400
+246,050
| +97% | +$1.95M | 0.37% | 82 |
|
|
2014
Q4 | $2.02M | Buy |
+254,350
| New | +$1.97M | 0.2% | 103 |
|
Other funds holding LRCX
HPC
MBI
AIM
Neville Rodie & Shaw's LRCX Position: Q2 2026 in Review
Neville Rodie & Shaw reduced its Lam Research (LRCX) stake by 2.9% in Q2 2026, selling an estimated $2.16M and leaving 243,027 shares worth $105M. The position accounts for 6.82% of the portfolio, ranked #2.
Neville Rodie & Shaw first reported a position in LRCX in Q4 2014 and has held it in 47 quarters since. 1,171 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Neville Rodie & Shaw held 243,027 shares of Lam Research worth $105M as of Q2 2026.
- Neville Rodie & Shaw sold 7,132 Lam Research shares in Q2 2026, an estimated $2.16M.
- Lam Research made up 6.82% of Neville Rodie & Shaw's portfolio in Q2 2026, its #2 holding.
- Neville Rodie & Shaw first reported a position in Lam Research in Q4 2014 and has held it in 47 quarters since.
- 1,171 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.